{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:16:01Z","timestamp":1792815361700,"version":"4.5.0"},"reference-count":187,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":46,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.jcmgh.2023.02.010","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T23:33:38Z","timestamp":1677108818000},"page":"1277-1292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease"],"prefix":"10.1016","volume":"15","author":[{"given":"Leke","family":"Wiering","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0557-3927","authenticated-orcid":false,"given":"Linda","family":"Hammerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2023.02.010_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"20","key":"10.1016\/j.jcmgh.2023.02.010_bib2","first-page":"2809","article-title":"Global NAFLD prevalence: a systematic review and meta-analysis","volume":"2022","author":"Le","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib3","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib4","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib5","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrd.2015.3","article-title":"Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies","volume":"15","author":"Musso","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib7","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00018-016-2161-x","article-title":"Pathogenesis of nonalcoholic steatohepatitis","volume":"73","author":"Liu","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib9","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib10","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib11","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib12","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3390\/ijms17091575","article-title":"Molecular pathogenesis of NASH","volume":"17","author":"Caligiuri","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib13","first-page":"31","article-title":"The role of innate immune cells in nonalcoholic fatty liver disease","volume":"14","author":"Nati","year":"2022","journal-title":"J\u00a0Innate Immun"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.112","article-title":"The metabolic basis of nonalcoholic steatohepatitis","volume":"3","author":"Chakravarthy","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib16","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/hep.30506","article-title":"The role of innate immune cells in nonalcoholic steatohepatitis","volume":"70","author":"Cai","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: an emerging player in the progression of NAFLD","volume":"17","author":"Sutti","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0037-1604480","article-title":"Macrophages in nonalcoholic fatty liver disease: a role model of pathogenic immunometabolism","volume":"37","author":"Krenkel","year":"2017","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066106","article-title":"The chemokine CCL3 promotes experimental liver fibrosis in mice","volume":"8","author":"Heinrichs","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib21","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1172\/JCI41732","article-title":"Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice","volume":"120","author":"Berres","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib22","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstrom","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study","volume":"155","author":"Vilar-Gomez","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2001-17550","article-title":"History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells","volume":"21","author":"Geerts","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib25","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.47162\/RJME.61.3.01","article-title":"Hepatic stellate cells - from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology","volume":"61","author":"Sufletel","year":"2020","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib28","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1872-034X.2012.01111.x","article-title":"Activated hepatic stellate cells mediate the differentiation of macrophages","volume":"43","author":"Chang","year":"2013","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib29","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","article-title":"Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis","volume":"75","author":"Xiong","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cmet.2020.10.026","article-title":"The power of plasticity-metabolic regulation of hepatic stellate cells","volume":"33","author":"Trivedi","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib31","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1073\/pnas.82.24.8681","article-title":"Hepatic lipocytes: the principal collagen-producing cells of normal rat liver","volume":"82","author":"Friedman","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib32","article-title":"Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis","volume":"11","author":"Wang","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.867940","article-title":"Hepatic stellate cell-immune interactions in NASH","volume":"13","author":"Carter","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib35","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/cells8050503","article-title":"Single cell RNA sequencing identifies subsets of hepatic stellate cells and myofibroblasts in liver fibrosis","volume":"8","author":"Krenkel","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib36","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.celrep.2019.10.024","article-title":"Single-cell transcriptomics uncovers zonation of function in the mesenchyme during liver fibrosis","volume":"29","author":"Dobie","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib37","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/hep.31743","article-title":"Heterogeneity of HSCs in a mouse model of NASH","volume":"74","author":"Rosenthal","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib38","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib39","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","article-title":"Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis","volume":"610","author":"Filliol","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/TP.0b013e318294caae","article-title":"Human hepatic stellate cells inhibit T-cell response through B7-H1 pathway","volume":"96","author":"Charles","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib41","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.4049\/jimmunol.1501737","article-title":"Hepatic stellate cells directly inhibit b cells via programmed death-ligand 1","volume":"196","author":"Li","year":"2016","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib42","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1097\/TP.0b013e31818bfd13","article-title":"Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner","volume":"86","author":"Jiang","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib43","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.24162","article-title":"Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice","volume":"53","author":"Chou","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1665-2681(19)32190-8","article-title":"Obesity-related non-alcoholic steatohepatitis and TGF-beta1 serum levels in relation to morbid obesity","volume":"1","author":"Sepulveda-Flores","year":"2002","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1479-5876-6-72","article-title":"Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?","volume":"6","author":"Tarantino","year":"2008","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib46","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/cells8111419","article-title":"TGF-beta in hepatic stellate cell activation and liver fibrogenesis-updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib47","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fimmu.2020.00553","article-title":"Phagocytosis of apoptotic cells in resolution of inflammation","volume":"11","author":"Kourtzelis","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3694","article-title":"Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-beta","volume":"9","author":"Hart","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib49","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/hep.1840380414","article-title":"p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts","volume":"38","author":"Furukawa","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib50","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0002-9440(10)62324-3","article-title":"Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2\/3 phosphorylation in rat hepatic stellate cells after acute liver injury","volume":"166","author":"Yoshida","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib51","first-page":"57","article-title":"TGF-beta\/Smad signaling in the injured liver","volume":"44","author":"Breitkopf","year":"2006","journal-title":"Z\u00a0Gastroenterol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib52","doi-asserted-by":"crossref","first-page":"37413","DOI":"10.1074\/jbc.274.52.37413","article-title":"Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription","volume":"274","author":"Engel","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib53","doi-asserted-by":"crossref","first-page":"27161","DOI":"10.1074\/jbc.274.38.27161","article-title":"Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression","volume":"274","author":"Hanafusa","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib54","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1083\/jcb.200704042","article-title":"Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix","volume":"179","author":"Wipff","year":"2007","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib55","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1083\/jcb.200312172","article-title":"Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1","volume":"165","author":"Annes","year":"2004","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib56","article-title":"miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression","author":"Qiu","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib57","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.2741\/4067","article-title":"Regulation of hepatic stellate cells by connective tissue growth factor","volume":"17","author":"Huang","year":"2012","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"4 Pt 1","key":"10.1016\/j.jcmgh.2023.02.010_bib58","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/jhep.2001.28055","article-title":"High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis","volume":"34","author":"Paradis","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib59","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10238-013-0229-6","article-title":"Inhibition of connective tissue growth factor suppresses hepatic stellate cell activation in\u00a0vitro and prevents liver fibrosis in\u00a0vivo","volume":"14","author":"Hao","year":"2014","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib60","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.ajpath.2014.06.009","article-title":"Transforming growth factor-beta-independent role of connective tissue growth factor in the development of liver fibrosis","volume":"184","author":"Sakai","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib61","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.4049\/jimmunol.1003260","article-title":"IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF-beta-independent Smad signaling","volume":"187","author":"Liu","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib62","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.3892\/mmr.2017.7641","article-title":"PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review)","volume":"16","author":"Ying","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib63","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1172\/JCI117497","article-title":"Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in\u00a0vivo and in culture","volume":"94","author":"Wong","year":"1994","journal-title":"The J Clin Invest"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib64","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jhep.2006.04.010","article-title":"Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice","volume":"45","author":"Czochra","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2015.01.036","article-title":"beta-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis","volume":"63","author":"Kocabayoglu","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib66","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hep.26661","article-title":"Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease","volume":"59","author":"Moylan","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib67","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ebiom.2019.04.036","article-title":"A\u00a0PDGFRbeta-based score predicts significant liver fibrosis in patients with chronic alcohol abuse, NAFLD and viral liver disease","volume":"43","author":"Lambrecht","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib68","doi-asserted-by":"crossref","first-page":"8905","DOI":"10.1016\/S0021-9258(18)81879-8","article-title":"Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation","volume":"264","author":"Heldin","year":"1989","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib69","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2007.07.032","article-title":"Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells","volume":"48","author":"Yang","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib70","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/labinvest.3700349","article-title":"Role for hedgehog signaling in hepatic stellate cell activation and viability","volume":"85","author":"Sicklick","year":"2005","journal-title":"Lab Invest"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib71","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.ajpath.2017.06.009","article-title":"Platelet-derived growth factor receptor alpha contributes to human hepatic stellate cell proliferation and migration","volume":"187","author":"Kikuchi","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib72","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/hep.25559","article-title":"Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease","volume":"55","author":"Guy","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070599","article-title":"Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis","volume":"8","author":"Hirsova","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib74","article-title":"Bevacizumab attenuates hepatic fibrosis in rats by inhibiting activation of hepatic stellate cells","volume":"8","author":"Huang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib75","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1053\/j.gastro.2014.01.061","article-title":"Vascular endothelial growth factor promotes fibrosis resolution and repair in mice","volume":"146","author":"Yang","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib76","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.26898","article-title":"Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma","volume":"59","author":"Fuchs","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib77","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.12659\/MSM.909901","article-title":"Inhibition of epidermal growth factor receptor (EGFR) reduces lipopolysaccharide (LPS)-induced activation and inflammatory cytokines in hepatic stellate cells in\u00a0vitro","volume":"24","author":"Qian","year":"2018","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib78","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib79","doi-asserted-by":"crossref","first-page":"6996","DOI":"10.3390\/ijms23136996","article-title":"Fibrogenic pathways in metabolic dysfunction associated fatty liver disease (MAFLD)","volume":"23","author":"Subramanian","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib80","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2012.02.028","article-title":"Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis","volume":"57","author":"Leroux","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib81","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","article-title":"The role of cholesterol in the pathogenesis of NASH","volume":"27","author":"Ioannou","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib82","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/liv.12170","article-title":"Trapping of oxidized LDL in lysosomes of Kupffer cells is a trigger for hepatic inflammation","volume":"33","author":"Bieghs","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib83","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2011.06.040","article-title":"Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis","volume":"141","author":"Van Rooyen","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib84","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/hep.25789","article-title":"Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis","volume":"57","author":"Savard","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib85","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/hep.30401","article-title":"Dietary lipids differentially shape nonalcoholic steatohepatitis progression and the transcriptome of Kupffer cells and infiltrating macrophages","volume":"70","author":"McGettigan","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib86","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A\u00a0lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib87","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jhep.2008.12.016","article-title":"Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH","volume":"50","author":"Caballero","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib88","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1194\/jlr.M034876","article-title":"Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis","volume":"54","author":"Ioannou","year":"2013","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib89","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1194\/jlr.M072454","article-title":"Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH","volume":"58","author":"Ioannou","year":"2017","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib90","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.gastro.2011.09.049","article-title":"A\u00a0high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells","volume":"142","author":"Teratani","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib91","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1038\/s41467-020-17881-3","article-title":"Triacylglycerol synthesis enhances macrophage inflammatory function","volume":"11","author":"Castoldi","year":"2020","journal-title":"Nature Commun"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib92","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jhep.2021.12.012","article-title":"Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease","volume":"76","author":"Govaere","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib93","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/s41467-017-02325-2","article-title":"Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4-MD2 complex","volume":"8","author":"Kim","year":"2017","journal-title":"Nature Commun"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib94","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/hep.30215","article-title":"Macrophage-specific hypoxia-inducible factor-1alpha contributes to impaired autophagic flux in nonalcoholic steatohepatitis","volume":"69","author":"Wang","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib95","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/labinvest.2009.93","article-title":"Curcumin eliminates oxidized LDL roles in activating hepatic stellate cells by suppressing gene expression of lectin-like oxidized LDL receptor-1","volume":"89","author":"Kang","year":"2009","journal-title":"Lab Invest"},{"issue":"4 Pt 1","key":"10.1016\/j.jcmgh.2023.02.010_bib96","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1053\/jhep.2001.27828","article-title":"Oxidized low-density lipoproteins bind to the scavenger receptor, CD36, of hepatic stellate cells and stimulate extracellular matrix synthesis","volume":"34","author":"Schneiderhan","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib97","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/hep.26429","article-title":"Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice","volume":"58","author":"Pradere","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib98","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00018-022-04319-w","article-title":"Macrophages evoke autophagy of hepatic stellate cells to promote liver fibrosis in NAFLD mice via the PGE2\/EP4 pathway","volume":"79","author":"Cao","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib99","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00535-018-1468-9","article-title":"Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease","volume":"53","author":"Kakisaka","year":"2018","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib100","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/path.2888","article-title":"Increased production of sonic hedgehog by ballooned hepatocytes","volume":"224","author":"Rangwala","year":"2011","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib101","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2015.10.007","article-title":"Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model","volume":"64","author":"Chung","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib102","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1053\/j.gastro.2012.07.115","article-title":"Hedgehog controls hepatic stellate cell fate by regulating metabolism","volume":"143","author":"Chen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib103","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","article-title":"Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease","volume":"15","author":"Min","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib104","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2020.03.010","article-title":"Cholesterol stabilizes TAZ in hepatocytes to promote experimental non-alcoholic steatohepatitis","volume":"31","author":"Wang","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib105","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cmet.2016.09.016","article-title":"Hepatocyte TAZ\/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis","volume":"24","author":"Wang","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib106","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/iub.2068","article-title":"Downregulation of hedgehog ligands in human simple steatosis may protect against nonalcoholic steatohepatitis: is TAZ a crucial regulator?","volume":"71","author":"Khajehahmadi","year":"2019","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib107","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jcmgh.2015.07.007","article-title":"Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-gamma","volume":"1","author":"Povero","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib108","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1159\/000453213","article-title":"Involvement of sphingosine 1-phosphate in palmitate-induced non-alcoholic fatty liver disease","volume":"40","author":"Al Fadel","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib109","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.lfs.2017.03.012","article-title":"Palmitic acid elicits hepatic stellate cell activation through inflammasomes and hedgehog signaling","volume":"176","author":"Duan","year":"2017","journal-title":"Life Sci"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib110","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat0344","article-title":"Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis","volume":"10","author":"Zhu","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib111","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe1692","article-title":"Hepatocyte TLR4 triggers inter-hepatocyte Jagged1\/Notch signaling to determine NASH-induced fibrosis","volume":"13","author":"Yu","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib112","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe5795","article-title":"The purinergic P2Y14 receptor links hepatocyte death to hepatic stellate cell activation and fibrogenesis in the liver","volume":"14","author":"Mederacke","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib113","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","article-title":"Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis","volume":"39","author":"McHedlidze","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib114","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.28973","article-title":"Hepatocyte autotaxin expression promotes liver fibrosis and cancer","volume":"65","author":"Kaffe","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib115","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/hep.31290","article-title":"The L-alpha-Lysophosphatidylinositol\/G protein-coupled receptor 55 system induces the development of nonalcoholic steatosis and steatohepatitis","volume":"73","author":"Fondevila","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib116","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216333","article-title":"A\u00a0type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis","volume":"14","author":"Booijink","year":"2022","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib117","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3748\/wjg.v24.i11.1239","article-title":"Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease","volume":"24","author":"Fujimori","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103532","article-title":"Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis: a prospective cohort study","volume":"9","author":"Pleli","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib119","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.lfs.2007.08.013","article-title":"Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity","volume":"81","author":"Watanabe","year":"2007","journal-title":"Life Sci"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib120","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.49882","article-title":"Obesity-linked suppression of membrane-bound O-Acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease","volume":"8","author":"Helsley","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib121","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib122","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/gutjnl-2020-320853","article-title":"Loss of hepatic Mboat7 leads to liver fibrosis","volume":"70","author":"Thangapandi","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib123","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jhep.2013.02.021","article-title":"Sphingosine kinase\/sphingosine 1-phosphate (S1P)\/S1P receptor axis is involved in liver fibrosis-associated angiogenesis","volume":"59","author":"Yang","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib124","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jhep.2010.08.028","article-title":"Sphingosine 1-phosphate (S1P)\/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility","volume":"54","author":"Li","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib125","doi-asserted-by":"crossref","first-page":"G300","DOI":"10.1152\/ajpgi.00222.2016","article-title":"Inhibition of sphingosine 1-phosphate signaling ameliorates murine nonalcoholic steatohepatitis","volume":"312","author":"Mauer","year":"2017","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib126","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jcmgh.2021.12.002","article-title":"Sphingosine 1-phosphate receptor 4 promotes nonalcoholic steatohepatitis by activating NLRP3 inflammasome","volume":"13","author":"Hong","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib127","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2011.12.044","article-title":"Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues","volume":"142","author":"Hernandez-Gea","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib128","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jhep.2011.07.010","article-title":"A\u00a0role for autophagy during hepatic stellate cell activation","volume":"55","author":"Thoen","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib129","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3892\/ijmm.2020.4778","article-title":"TGFbeta1induced autophagy activates hepatic stellate cells via the ERK and JNK signaling pathways","volume":"47","author":"Zhang","year":"2021","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib130","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1080\/15548627.2017.1356550","article-title":"Lipopolysaccharide mediates hepatic stellate cell activation by regulating autophagy and retinoic acid signaling","volume":"13","author":"Chen","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib131","doi-asserted-by":"crossref","DOI":"10.1038\/srep39342","article-title":"The XBP1 arm of the unfolded protein response induces fibrogenic activity in hepatic stellate cells through autophagy","volume":"6","author":"Kim","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib132","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2013.02.016","article-title":"Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy","volume":"59","author":"Hernandez-Gea","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib133","article-title":"Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators","volume":"4","author":"Pastore","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108626","article-title":"Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH","volume":"34","author":"Daemen","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib135","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.immuni.2019.08.017","article-title":"Stellate cells, hepatocytes, and endothelial cells imprint the Kupffer cell identity on monocytes colonizing the liver macrophage niche","volume":"51","author":"Bonnardel","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib136","article-title":"Activated hepatic stellate cells induce infiltration and formation of CD163(+) macrophages via CCL2\/CCR2 pathway","volume":"8","author":"Xi","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib137","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1172\/JCI24798","article-title":"Attenuated liver fibrosis in the absence of B cells","volume":"115","author":"Novobrantseva","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib138","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1053\/j.gastro.2004.04.062","article-title":"Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes","volume":"127","author":"Safadi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib139","first-page":"464","article-title":"Role of intrahepatic B cells in non-alcoholic fatty liver disease by secreting pro-inflammatory cytokines and regulating intrahepatic T cells","volume":"17","author":"Zhang","year":"2016","journal-title":"J\u00a0Dig Dis"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib140","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/hep.27761","article-title":"Liver fibrosis occurs through dysregulation of MyD88-dependent innate B-cell activity","volume":"61","author":"Thapa","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib141","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes","volume":"26","author":"Wolf","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib142","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/hep4.1041","article-title":"Hepatic natural killer T-cell and CD8+ T-cell signatures in mice with nonalcoholic steatohepatitis","volume":"1","author":"Bhattacharjee","year":"2017","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib143","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1038\/s41467-021-24734-0","article-title":"CD8(+) tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells","volume":"12","author":"Koda","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib144","doi-asserted-by":"crossref","first-page":"eaar7754","DOI":"10.1126\/sciimmunol.aar7754","article-title":"Type 3 cytokines IL-17A and IL-22 drive TGF-beta-dependent liver fibrosis","volume":"3","author":"Fabre","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib145","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/gutjnl-2011-301857","article-title":"NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease","volume":"61","author":"Syn","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib146","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1089\/ars.2014.6108","article-title":"Myeloperoxidase-hepatocyte-stellate cell cross talk promotes hepatocyte injury and fibrosis in experimental nonalcoholic steatohepatitis","volume":"23","author":"Pulli","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib147","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jcmgh.2018.01.003","article-title":"Neutrophil-hepatic stellate cell interactions promote fibrosis in experimental steatohepatitis","volume":"5","author":"Zhou","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib148","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151063","article-title":"TLR4-dependent secretion by hepatic stellate cells of the neutrophil-chemoattractant CXCL1 mediates liver response to gut microbiota","volume":"11","author":"Bigorgne","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib149","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/MOG.0000000000000349","article-title":"Intestinal microbiota and nonalcoholic steatohepatitis","volume":"33","author":"Brandl","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib150","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib151","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1159\/000373976","article-title":"TGF-beta regulates hepatocellular carcinoma progression by inducing Treg cell polarization","volume":"35","author":"Shen","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib152","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.4049\/jimmunol.1201937","article-title":"Hepatic stellate cells preferentially induce Foxp3+ regulatory T cells by production of retinoic acid","volume":"190","author":"Dunham","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib153","article-title":"The love-hate relationship between TGF-beta signaling and the immune system during development and tumorigenesis","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib154","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1053\/j.gastro.2012.06.036","article-title":"Deactivation of hepatic stellate cells during liver fibrosis resolution in mice","volume":"143","author":"Troeger","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib155","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.1201840109","article-title":"Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis","volume":"109","author":"Kisseleva","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib156","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3390\/biomedicines9040365","article-title":"Hepatic stellate cell activation and inactivation in NASH-fibrosis-roles as putative treatment targets?","volume":"9","author":"Zisser","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib157","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150059","article-title":"GATA4 induces liver fibrosis regression by deactivating hepatic stellate cells","volume":"6","author":"Arroyo","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib158","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/hep.30965","article-title":"A\u00a0deactivation factor of fibrogenic hepatic stellate cells induces regression of liver fibrosis in mice","volume":"71","author":"Nakano","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib159","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1053\/j.gastro.2020.01.027","article-title":"Identification of lineage-specific transcription factors that prevent activation of hepatic stellate cells and promote fibrosis resolution","volume":"158","author":"Liu","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib160","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/hep.26697","article-title":"Chemokine receptor CCR6-dependent accumulation of gammadelta T cells in injured liver restricts hepatic inflammation and fibrosis","volume":"59","author":"Hammerich","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib161","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","article-title":"Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners","volume":"130","author":"Radaeva","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib162","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jhep.2005.12.025","article-title":"Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC","volume":"45","author":"Melhem","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib163","first-page":"1858","article-title":"CCR1 and CCR5 promote hepatic fibrosis in mice","volume":"119","author":"Seki","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib164","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.1002\/jcp.26485","article-title":"Effects of treatment with Maraviroc a CCR5 inhibitor on a human hepatic stellate cell line","volume":"233","author":"Coppola","year":"2018","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib165","series-title":"Maraviroc or metformin does not lower liver fat in people with HIV and NAFLD","author":"Mascolini","year":"2021"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib166","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jhep.2020.11.045","article-title":"Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease","volume":"74","author":"Boyer-Diaz","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib167","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/hep.26461","article-title":"Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha\/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"58","author":"Staels","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib168","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/hep.32235","article-title":"A\u00a0GLP-1\/GLP-2 receptor dual agonist to treat NASH: targeting the gut-liver axis and microbiome","volume":"75","author":"Kim","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib171","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2019.11.296","article-title":"Effects of belapectin, an inhibitor of galectin-3, in patients with nonalcoholic steatohepatitis with cirrhosis and portal hypertension","volume":"158","author":"Chalasani","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib175","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2018.07.006","article-title":"Simtuzumab is ineffective for patients with bridging fibrosis or compensated cirrhosis caused by nonalcoholic steatohepatitis","volume":"155","author":"Harrison","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib181","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-230X-14-131","article-title":"Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C","volume":"14","author":"Flores-Contreras","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib182","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s12072-020-10069-3","article-title":"Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study","volume":"14","author":"Poo","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib173","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/hep.32181","article-title":"BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trial","volume":"75","author":"Lawitz","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2020.105881","article-title":"The therapeutic potential of galectin-3 inhibition in fibrotic disease","volume":"130","author":"Slack","year":"2021","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083481","article-title":"Therapy of experimental NASH and fibrosis with galectin inhibitors","volume":"8","author":"Traber","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib172","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1074\/jbc.TM118.002812","article-title":"Roles of the endoplasmic reticulum-resident, collagen-specific molecular chaperone Hsp47 in vertebrate cells and human disease","volume":"294","author":"Ito","year":"2019","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib174","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/gutjnl-2016-312473","article-title":"Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal","volume":"66","author":"Ikenaga","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib176","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68223-8","article-title":"Anti-integrin alpha(v) therapy improves cardiac fibrosis after myocardial infarction by blunting cardiac PW1(+) stromal cells","volume":"10","author":"Bouvet","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib177","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/nm.3282","article-title":"Targeting of alphav integrin identifies a core molecular pathway that regulates fibrosis in several organs","volume":"19","author":"Henderson","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib178","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41573-021-00284-4","article-title":"Emerging therapeutic opportunities for integrin inhibitors","volume":"21","author":"Slack","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib179","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91187-2","article-title":"Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD\/NASH","volume":"11","author":"Escutia-Gutierrez","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116982","article-title":"Pirfenidone alleviates concanavalin A-induced liver fibrosis in mice","volume":"239","author":"Salah","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib183","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00029330-200801020-00013","article-title":"Effect of angiotensin II and angiotensin II type 1 receptor antagonist on the proliferation, contraction and collagen synthesis in rat hepatic stellate cells","volume":"121","author":"Liu","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib184","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/hep.21638","article-title":"Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis","volume":"45","author":"Hirose","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib185","doi-asserted-by":"crossref","first-page":"7841","DOI":"10.1038\/s41598-017-08334-x","article-title":"Angiotensin II induces connective tissue growth factor expression in human\u00a0hepatic stellate cells by a transforming growth factor beta-independent mechanism","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib186","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/hep.30696","article-title":"Pharmacologic inhibition of epidermal growth factor receptor suppresses nonalcoholic fatty liver disease in a murine fast-food diet model","volume":"70","author":"Bhushan","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.02.010_bib187","series-title":"Intercept Resubmits New Drug Application to U.S. FDA for Obeticholic Acid in Patients with Liver Fibrosis due to NASH","author":"Intercept Pharmaceuticals","year":"2022"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X23000292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X23000292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:34:00Z","timestamp":1762454040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X23000292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":187,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"alternative-id":["S2352345X23000292"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2023.02.010","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2023.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}